LOGIN  |  REGISTER
Amneal Pharmaceuticals
C4 Therapeutics

InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality Care

April 24, 2024 | Last Trade: US$4.66 0.04 -0.85

LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), the healthcare industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), celebrates the grand opening of its newest center in California.

As part of this launch, InnovAge California PACE will host a lively celebration today, welcoming local officials, community organizations, care partners, and the public, to tour its PACE center based in the historic Los Angeles Crenshaw neighborhood. Today’s guests will tour the 22,000 square foot, two-level renovated center -- which includes a medical clinic with exam rooms, dining room, four day rooms, quiet room, outdoor patio, and other amenities. The program’s service area extends beyond Crenshaw, providing care and support to seniors residing in West and South Los Angeles.

“InnovAge provides critical healthcare programs where seniors and their families need us most,” says InnovAge President and CEO Patrick Blair. “We’re proud to expand our footprint in California and ensure seniors continue to receive the gold standard of community-based care while living happier, more independent lives.”

For more than 30 years, InnovAge has been providing integrated PACE healthcare and support services to seniors, through a personalized approach that encompasses transportation, in-home care, medication management, specialty care, physical therapy, occupational therapy, exercise, social services, meals and nutrition, socialization, recreational activities, and more. This care is delivered at no cost to seniors with Medicare and Medi-Cal (Medicaid) coverage, helping seniors that might otherwise need nursing home care to continue to live independently.

InnovAge tailors healthcare services to each participant, through customized care plans developed in partnership with seniors, their loved ones, and the company’s healthcare providers, helping to empower seniors and promote independence and well-being. InnovAge centers are embedded in the communities seniors live in and are uniquely positioned to help them holistically. InnovAge currently serves seniors in California, Colorado, Florida, New Mexico, Pennsylvania, and Virginia.

This is the company’s third center in California, with efforts focused on securing additional future locations.

Media Contact:
Lara Hazenfield
InnovAge Public Relations Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
720-884-7568

About InnovAge

InnovAge is a market leader in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). With a mission of enabling older adults to age independently in their own homes for as long as safely possible, InnovAge’s patient-centered care model is designed to improve the quality of care its participants receive while reducing over-utilization of high-cost care settings. InnovAge believes its PACE healthcare model is one in which all constituencies — participants, their families, providers, and government payors — “win.” As of December 31, 2023, InnovAge served approximately 6,780 participants across 18 centers in five states. www.InnovAge.com.

Assertio

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB